Your browser doesn't support javascript.
loading
Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis.
Burdett, Sarah; Stewart, Lesley.
  • Burdett S; Meta-analysis Group, MRC Clinical Trials Unit, 222 Euston Road, London NW12DA, UK. sb@ctu.mrc.ac.uk
Lung Cancer ; 47(1): 81-3, 2005 Jan.
Article en En | MEDLINE | ID: mdl-15603857
ABSTRACT
We report an updated systematic review and individual patient data meta-analysis of the effectiveness of postoperative radiotherapy (PORT) in non-small-cell lung cancer. Results continue to show PORT to be detrimental, with an 18% relative increase in the risk of death. Similar detriments were observed for local recurrence-free survival, distant recurrence-free survival and overall recurrence-free survival. There continues to be evidence that the effects of PORT are more harmful in those patients with stage I disease than those with stage II disease.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2005 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2005 Tipo del documento: Article